Submit your research
Start your submission and get more impact for your research by publishing with us.
- Frontiers in Cardiovascular Medicine
- Cardio-Oncology
Author guidelines
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Editor guidelines
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Peer review
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Publishing fees
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Journal notices
Submission closing: Specialty Chief Editor's Collection on Non-Invasive Cardiovascular Imaging
Submissions close 30 May 2026—last call to join the collection curated by Sebastian Kelle, our Specialty Chief Editor for Cardiovascular Imaging, spanning AI diagnostics, genetics, cardiomyopathies, heart failure, and prevention
Rheumatic Heart Disease: global trends and emerging mechanisms
A preventable disease still claiming young lives. This ISACB-led collection explores RHD’s global epidemiology and the biology behind rheumatic valve injury—autoimmunity, fibrosis, sex-specific responses, omics, and vaccines. Submit by 30 September 2026.
Reimagining cardiac rehabilitation: lessons from history for a post‑MI future
Explore how cardiac rehabilitation evolved from strict bed rest to modern post‑MI care. Julie Redfern (University of Sydney) and Tom Briffa (University of Western Australia) trace its history and outline how programs must modernize for today’s patients
Featured Article: Update on Sex-Specific Risk Factors in Cardiovascular Disease
Pregnancy, menopause, PMOS: Dr. Garima Sharma, Director of Inova's Women's Heart Program and a leading voice in women's cardiovascular health, reveals how reproductive history reshapes heart disease risk. Revisit the review driving today’s conversation.
Sea buckthorn: an ancient berry with modern cardiovascular potential
Rich in flavonoids, omega fatty acids and polyphenols, sea buckthorn shows measurable effects on inflammation, lipid metabolism, oxidative stress and platelet activity — positioning it as a promising natural strategy for cardiovascular disease.
Editors
See alljun-ichi abe
University of Texas MD Anderson Cancer Center
Houston, United States
Specialty Chief Editor
Cardio-Oncology
joerg herrmann
Mayo Clinic
Rochester, United States
Specialty Chief Editor
Cardio-Oncology
louisa antoni
Leiden University Medical Center (LUMC)
Leiden, Netherlands
Associate Editor
Cardio-Oncology
reto asmis
School of Medicine, Wake Forest University
Winston-Salem, United States
Associate Editor
Cardio-Oncology
